by NeuroQuest | Dec 12, 2016 | News, Uncategorized
The saying goes, “Rome wasn’t built in a day.” Scientists understand the depth of that idiom all too well. Demonstrable progress in Alzheimer’s research can be elusive; setbacks are common, breakthroughs are rare, but through it all –...
by NeuroQuest | Jan 20, 2016 | News, Research
The latest work from the research team of NeuroQuest Founder and Chief Scientist, Dr. Michal Schwartz, published in Nature Medicine was highlighted in the U.K. Telegraph showing the potential certain cancer-fighting drugs may have in fighting Alzheimer’s...
by NeuroQuest | Dec 10, 2015 | Clinical update, News
NeuroQuest Development Center, Inc., announced they have entered into a service agreement with the University of California, San Diego for collection and processing of blood samples for their U.S. clinical validation trials. The South Carolina-based biotech company is...
by NeuroQuest | Nov 3, 2015 | Awards, News, Research
Dr. Michal Schwartz was awarded the Blumberg Outstanding Medical Research Scientist Prize on November 3, 2015 for her groundbreaking research in the connection between the brain and the immune system. “There was a scientific dogma that there is no relationship between...
by NeuroQuest | Sep 22, 2015 | News, Research
“In the past, the brain was considered an autonomous organ, self-contained and completely separate from the body’s immune system. But over the past twenty years, neuroimmunologist Michal Schwartz, together with her research team, not only has overturned this...
by NeuroQuest | Aug 19, 2015 | News, Research
Breaking the body’s immune tolerance to tumors has been the biggest advance for cancer treatment in recent years. Now, scientists have reported that the same strategy might be successful against neurodegenerative diseases. The notion that escape from immune...
